Maciej T. Czajkowski

Maciej T. Czajkowski

Auto-generated profile, based on publicly available information

Maciej T. Czajkowski

Max-Delbrück-Center for Molecular Medicine, Robert-Roessle-Straße 10, 13125 Berlin, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Developmental Cell
Verified
Journal Article
Closed access
DBDominique Bröhl
Dominique Bröhl
EVElena Vasyutina
Elena Vasyutina
MCMaciej T. Czajkowski
Maciej T. Czajkowski
JGJoscha Griger
Joscha Griger
CRClaudia Rassek
Claudia Rassek
CBCarmen Birchmeier
Carmen Birchmeier

7 October 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
RERebecca L. Eccles
Rebecca L. Eccles
MCMaciej T. Czajkowski
Maciej T. Czajkowski
CBCarolin Barth
Carolin Barth
PMPaul Markus Müller
Paul Markus Müller
EMErik McShane
Erik McShane
OROliver Rocks
Oliver Rocks
Protein kinase A is a key mediator of cAMP signalling downstream of G-protein-coupled receptors, a signalling pathway conserved in all eukaryotes. cAMP binding to the regulatory subunits (PKAR) relieves their inhibition of the catalytic subunits (PKAC). Here we report that ARHGAP36 combines two distinct inhibitory mechanisms to antagonise PKA signalling. First, it blocks PKAC activity via a pseudosubstrate motif, akin to the mechanism employed by the protein kinase inhibitor proteins. Second, it targets PKAC for rapid ubiquitin-mediated lysosomal degradation, a pathway usually reserved for transmembrane receptors. ARHGAP36 thus dampens the sensitivity of cells to cAMP. We show that PKA inhibition by ARHGAP36 promotes derepression of the Hedgehog signalling pathway, thereby providing a simple rationale for the upregulation of ARHGAP36 in medulloblastoma. Our work reveals a new layer of PKA regulation that may play an important role in development and disease.

1 November 2014 in Developmental Biology
Verified
Journal Article
Open access
MCMaciej T. Czajkowski
Maciej T. Czajkowski
CRClaudia Rassek
Claudia Rassek
DLDiana C. Lenhard
Diana C. Lenhard
DBDominique Bröhl
Dominique Bröhl
CBCarmen Birchmeier
Carmen Birchmeier
Craniofacial and trunk skeletal muscles are evolutionarily distinct and derive from cranial and somitic mesoderm, respectively. Different regulatory hierarchies act upstream of myogenic regulatory factors in cranial and somitic mesoderm, but the same core regulatory network - MyoD, Myf5 and Mrf4 - executes the myogenic differentiation program. Notch signaling controls self-renewal of myogenic progenitors as well as satellite cell homing during formation of trunk muscle, but its role in craniofacial muscles has been little investigated. We show here that the pool of myogenic progenitor cells in craniofacial muscle of Dll1(LacZ/Ki) mutant mice is depleted in early fetal development, which is accompanied by a major deficit in muscle growth. At the expense of progenitor cells, supernumerary differentiating myoblasts appear transiently and these express MyoD. The progenitor pool in craniofacial muscle of Dll1(LacZ/Ki) mutants is largely rescued by an additional mutation of MyoD. We conclude from this that Notch exerts its decisive role in craniofacial myogenesis by repression of MyoD. This function is similar to the one previously observed in trunk myogenesis, and is thus conserved in cranial and trunk muscle. However, in cranial mesoderm-derived progenitors, Notch signaling is not required for Pax7 expression and impinges little on the homing of satellite cells. Thus, Dll1 functions in satellite cell homing and Pax7 expression diverge in cranial- and somite-derived muscle.